Clinical trial
Tetracycline-Derivatives for Treatment of Cerebral Arteriovenous Malformations…
NCT00243893 · University of California, San Francisco, Other · Completed
Key facts
| NCT number | NCT00243893 |
|---|---|
| Title | Tetracycline-Derivatives for Treatment of Cerebral Arteriovenous Malformations and Aneurysms |
| Official title | Tetracycline-Derivatives for Treatment of Cerebral Arteriovenous Malformations and Aneurysms |
| Lead sponsor | University of California, San Francisco, Other |
| Collaborators | National Institute of Neurological Disorders and Stroke (NINDS) NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Aneurysms, Arteriovenous Malformations |
| Intervention type | Drug |
| Interventions | minocycline, doxycycline |
| Enrollment | 26 |
| Start date | Jul 1, 2004 |
| Primary completion | Oct 1, 2008 |
| Completion | Oct 1, 2008 |
| First posted | Oct 25, 2005 |
| Last update posted | Oct 9, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: